Lv7
5498 积分 2021-05-07 加入
EULAR points to consider for the definition of clinical and imaging features suspicious for progression from psoriasis to psoriatic arthritis
5小时前
已完结
Fibroblast function in psoriatic arthritis. I. Alteration of cell kinetics and growth factor responses
2个月前
已关闭
Potential difficult-to-treat psoriatic arthritis real-world prevalence and contributing factors
5个月前
已完结
A novel nomogram to predict psoriatic arthritis in patients with plaque psoriasis
5个月前
已完结
Biomarkers in Psoriasis and Psoriatic Arthritis: Where Are We Now?
5个月前
已关闭
Management of rheumatoid arthritis in China: a study of the implementation of 2019 EULAR recommendations
8个月前
已关闭
Management of rheumatoid arthritis in China: a study of the implementation of 2019 EULAR recommendations
8个月前
已完结
mTOR signaling cascade in psoriatic disease: Double kinase mtor inhibitor a novel therapeutic target
9个月前
已关闭
Fibroblast function in psoriatic arthritis. I. Alteration of cell kinetics and growth factor responses
9个月前
已关闭
The European Scleroderma Trials and Research group (EUSTAR) task force for the development of revised activity criteria for systemic sclerosis: derivation and validation of a preliminarily revised EUSTAR activity index
11个月前
已完结
皖公网安备34019202002308
